Listar por autor "García Donday, M"
Mostrando ítems 1-1 de 1
-
Is the withdrawal of anti-tumour necrosis factor in inflammatory bowel disease patients in remission feasible without increasing the risk of relapse? Results from the randomised clinical trial of GETECCU (EXIT) . Chaparro, M; García Donday, M; Riestra, S; Van Domselaar, M.; Gisbert, J P (Journal of Crohn's and Colitis, 2023)